Journal of Pathology and Translational Medicine (대한병리학회지)

The Korean Society of Pathologists (대한병리학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence and Genotype Distribution of Cervical Human Papillomavirus DNA in Korean Women: A Multicenter Study

Hong, Sung-Ran;Kim, In-Sun;Kim, Dong-Won;Kim, Mi-Jin;Kim, Ae-Ree;Kim, Young-Ok;Kim, Hye-Sun;Rha, Seo-Hee;Park, Gyeong-Sin;Park, Yong-Koo;Park, Yong-Wook;Park, Ho-Sung;Suh, Kwang-Sun;Sohn, Jin-Hee;Shin, Mi-Kyung;Oh, Hoon-Kyu;Yun, Ki-Jung;Yoon, Hye-Kyoung;Lee, Shi-Nae;Lee, Ah-Won;Lee, Hyo-Jin;Cho, Hyun-Yee;Choi, Chan;Jung, Woon-Won

  • Published : 2009.08.25
⟨ Previous Next ⟩

Abstract

Background : DNA prevalence and type distribution of human papillomavirus (HPV) varies geographically. We investigated HPV prevalence and type distribution in Korean women using the MyHPV DNA chip testing. Methods : A total of 2,368 women from five regions of the country underwent Pap smear examination and MyHPV chip testing. Results : Overall HPV positivity was 15.8% and 78.4% in women with normal and abnormal cytology, respectively. Highrisk HPV infection was strongly correlated with cytological atypia. In women with abnormal cytology, the five most common HPV types were 16, 58, 18, 52, and 56/53, and HPV16 was significantly the most common type in most geographical regions. After HPV16, HPV58, and 52 were the next most frequently detected types. Women with normal cytology, in contrast, showed heterogeneity in HPV type distribution. High-grade intraepithelial lesions infected with HPV16, 18, 31 or 45 are more likely to progress to carcinoma. Conclusions : The HPV chip test can provide useful data regarding HPV positivity and type. The most common HPV type in Korean women with abnormal cytology is HPV16, with HPV58 and 52 being frequently present. Our data may have important implications for vaccination programs and the development of cervical screening.

Keywords

References

  1. Wallin KL, Wiklund F, Angstro_m T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633-8 https://doi.org/10.1056/NEJM199911253412201
  2. Munoz N, Bosch FX, de Sanjose S, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27 https://doi.org/10.1056/NEJMoa021641
  3. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95: 46-52 https://doi.org/10.1093/jnci/95.1.46
  4. Wright TC Jr, Lorincz A, Ferris DG, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998; 178: 962-6 https://doi.org/10.1016/S0002-9378(98)70531-9
  5. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GJ. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol 1992; 11: 204-9 https://doi.org/10.1097/00004347-199207000-00006
  6. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52: 342-62 https://doi.org/10.3322/canjclin.52.6.342
  7. Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003; 188: 1401-5 https://doi.org/10.1067/mob.2003.456
  8. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB. Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003; 189: 295-304 https://doi.org/10.1067/mob.2003.633
  9. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57: 7-28 https://doi.org/10.3322/canjclin.57.1.7
  10. de Sanjos$\acute{e}$ S, Diaz M, Castellsagu$\acute{e}$ X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-9 https://doi.org/10.1016/S1473-3099(07)70158-5
  11. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer 2003; 88: 63-73 https://doi.org/10.1038/sj.bjc.6600688
  12. Jung WW, Chun T, Sul D, et al. Strategies against human papillomavirus infection and cervical cancer. J Microbiol 2004; 42: 255-66
  13. Hong SH, Lee DH, Shin HR. Prevalence of human papillomavirus infection in women in South Korea: incidence of positive HPV DNA and anti-VLPs in residents of Busan city. Korean J Cytopathol 2004; 15: 17-27
  14. Hwang T. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999; 14: 593-9 https://doi.org/10.3346/jkms.1999.14.6.593
  15. Kahng J, Lee HJ. Clinical efficacy of HPV DNA Chip test in the era of HPV vaccination: 1,211 cases, a single institution study. Korean J Lab Med 2008; 28:70-8 https://doi.org/10.3343/kjlm.2008.28.1.70
  16. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003; 97: 1672-80 https://doi.org/10.1002/cncr.11235
  17. Sherman ME, Solomon D, Schiffman M. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 2001; 116: 386-94 https://doi.org/10.1309/JM3V-U4HP-W8HJ-68XV
  18. Bandyopadhyay S, Austin RM, Dabbs D, Zhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med 2008; 132: 1874-81
  19. The Atypical Squamous Cells of Undetermined Significance/Low- Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92: 397-402 https://doi.org/10.1093/jnci/92.5.397
  20. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including "pseudo- koilocytosis". Mod Pathol 1995; 8: 408-12
  21. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GJ. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol 1992; 11: 204-9 https://doi.org/10.1097/00004347-199207000-00006
  22. Solomon D, Schiffman M, Tarone R; ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9 https://doi.org/10.1093/jnci/93.4.293
  23. Bae JH, Lee SJ, Kim CJ, et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008; 18: 788-94
  24. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5 https://doi.org/10.1038/sj.bjc.6601024
  25. Bao YP, Li N, Smith JS, Qiao YL, ACCPAB Members. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008; 18: 71-9
  26. Clifford GM, Gallus S, Herrero R, et al. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-8 https://doi.org/10.1016/S0140-6736(05)67069-9
  27. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1796-807 https://doi.org/10.1086/428850